Figure 2.
Change from baseline to week 24 in DAS28-ESR for subgroups of patients with moderate-to-severe rheumatoid arthritis randomised to MSB11456 or EU-approved tocilizumab, core period ITT analysis set.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.